Most genes have multiple polyadenylation sites (PAS), which are often selected in a tissue-specific manner, altering protein products and affecting mRNA stability, subcellular localization and/or translability. Here we studied the polyadenylation mechanisms associated to the beta-adducin gene (Add2). We have previously shown that the Add2 gene has a very tight regulation of alternative polyadenylation, using proximal PAS in erythroid tissues, and a distal one in brain. Using chimeric minigenes and cell transfections we identified the core elements responsible for polyadenylation at the distal PAS. Deletion of either the hexanucleotide motif (Hm) or the downstream element (DSE) resulted in reduction of mature mRNA levels and activation of cryptic PAS, suggesting an important role for the DSE in polyadenylation of the distal Add2 PAS. Point mutation of the UG repeats present in the DSE, located immediately after the cleavage site, resulted in a reduction of processed mRNA and in the activation of the same cryptic site. RNA-EMSA showed that this region is active in forming RNA-protein complexes. Competition experiments showed that RNA lacking the DSE was not able to compete the RNA-protein complexes, supporting the hypothesis of an essential important role for the DSE. Next, using a RNA-pull down approach we identified some of the proteins bound to the DSE. Among these proteins we found PTB, TDP-43, FBP1 and FBP2, nucleolin, RNA helicase A and vigilin. All these proteins have a role in RNA metabolism, but only PTB has a reported function in polyadenylation. Additional experiments are needed to determine the precise functional role of these proteins in Add2 polyadenylation.
References
[1]
Martin G, Gruber AR, Keller W, Zavolan M (2012) Genome-wide analysis of pre-mRNA 3′ end processing reveals a decisive role of human cleavage factor I in the regulation of 3′ UTR length. Cell Rep 1: 753–763.
[2]
Yao C, Biesinger J, Wan J, Weng L, Xing Y, et al. (2012) Transcriptome-wide analyses of CstF64-RNA interactions in global regulation of mRNA alternative polyadenylation. Proc Natl Acad Sci U S A 109: 18773–18778.
[3]
Darmon SK, Lutz CS (2012) Novel upstream and downstream sequence elements contribute to polyadenylation efficiency. RNA Biol 9.
[4]
Castelo-Branco P, Furger A, Wollerton M, Smith C, Moreira A, et al. (2004) Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol Cell Biol 24: 4174–4183.
[5]
Chen F, Wilusz J (1998) Auxiliary downstream elements are required for efficient polyadenylation of mammalian pre-mRNAs. Nucleic Acids Res 26: 2891–2898.
[6]
Hall-Pogar T, Liang S, Hague LK, Lutz CS (2007) Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3′-UTR. RNA 13: 1103–1115.
[7]
Moreira A, Takagaki Y, Brackenridge S, Wollerton M, Manley JL, et al. (1998) The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3′ end formation by two distinct mechanisms. Genes Dev 12: 2522–2534.
[8]
Arhin GK, Boots M, Bagga PS, Milcarek C, Wilusz J (2002) Downstream sequence elements with different affinities for the hnRNP H/H′ protein influence the processing efficiency of mammalian polyadenylation signals. Nucleic Acids Res 30: 1842–1850.
[9]
Brown PH, Tiley LS, Cullen BR (1991) Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences. J Virol 65: 3340–3343.
[10]
Carswell S, Alwine JC (1989) Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Mol Cell Biol 9: 4248–4258.
[11]
Natalizio BJ, Muniz LC, Arhin GK, Wilusz J, Lutz CS (2002) Upstream elements present in the 3′-untranslated region of collagen genes influence the processing efficiency of overlapping polyadenylation signals. J Biol Chem 277: 42733–42740.
[12]
Valsamakis A, Zeichner S, Carswell S, Alwine JC (1991) The human immunodeficiency virus type 1 polyadenylylation signal: a 3′ long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. Proc Natl Acad Sci U S A 88: 2108–2112.
[13]
Nunes NM, Li W, Tian B, Furger A (2010) A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence. EMBO J 29: 1523–1536.
[14]
Derti A, Garrett-Engele P, Macisaac KD, Stevens RC, Sriram S, et al. (2012) A quantitative atlas of polyadenylation in five mammals. Genome Res 22: 1173–1183.
[15]
Andreassi C, Riccio A (2009) To localize or not to localize: mRNA fate is in 3′UTR ends. Trends Cell Biol 19: 465–474.
[16]
de Moor CH, Meijer H, Lissenden S (2005) Mechanisms of translational control by the 3′ UTR in development and differentiation. Semin Cell Dev Biol 16: 49–58.
[17]
Costessi L, Devescovi G, Baralle FE, Muro AF (2006) Brain-specific promoter and polyadenylation sites of the beta-adducin pre-mRNA generate an unusually long 3′-UTR. Nucleic Acids Res 34: 243–253.
[18]
Porro F, Rosato-Siri M, Leone E, Costessi L, Iaconcig A, et al. (2010) beta-adducin (Add2) KO mice show synaptic plasticity, motor coordination and behavioral deficits accompanied by changes in the expression and phosphorylation levels of the alpha- and gamma-adducin subunits. Genes Brain Behav 9: 84–96.
[19]
Matsuoka Y, Li X, Bennett V (2000) Adducin: structure, function and regulation. Cell Mol Life Sci 57: 884–895.
[20]
Gilligan DM, Lozovatsky L, Gwynn B, Brugnara C, Mohandas N, et al. (1999) Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. Proc Natl Acad Sci U S A 96: 10717–10722.
[21]
Muro AF, Marro ML, Gajovic S, Porro F, Luzzatto L, et al. (2000) Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice. Blood 95: 3978–3985.
[22]
Tripodi G, Piscone A, Borsani G, Tisminetzky S, Salardi S, et al. (1991) Molecular cloning of an adducin-like protein: evidence of a polymorphism in the normotensive and hypertensive rats of the Milan strain. Biochem Biophys Res Commun 177: 939–947.
[23]
Matsuoka Y, Li X, Bennett V (1998) Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin- actin complexes and occurs in many cells, including dendritic spines of neurons. J Cell Biol 142: 485–497.
[24]
Seidel B, Zuschratter W, Wex H, Garner CC, Gundelfinger ED (1995) Spatial and sub-cellular localization of the membrane cytoskeleton- associated protein alpha-adducin in the rat brain. Brain Res 700: 13–24.
[25]
Bednarek E, Caroni P (2011) beta-Adducin is required for stable assembly of new synapses and improved memory upon environmental enrichment. Neuron 69: 1132–1146.
[26]
Pielage J, Bulat V, Zuchero JB, Fetter RD, Davis GW (2011) Hts/Adducin controls synaptic elaboration and elimination. Neuron 69: 1114–1131.
[27]
Rabenstein RL, Addy NA, Caldarone BJ, Asaka Y, Gruenbaum LM, et al. (2005) Impaired synaptic plasticity and learning in mice lacking beta-adducin, an actin-regulating protein. J Neurosci 25: 2138–2145.
[28]
Mardon HJ, Sebastio G, Baralle FE (1987) A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res 15: 7725–7733.
Vibe-Pedersen K, Kornblihtt AR, Baralle FE (1984) Expression of a human alpha-globin/fibronectin gene hybrid generates two mRNAs by alternative splicing. Embo J 3: 2511–2516.
[31]
Morgan M, Iaconcig A, Muro AF (2012) Identification of 3[prime] gene ends using transcriptional and genomic conservation across vertebrates. BMC Genomics 13: 708.
[32]
Tian B, Hu J, Zhang H, Lutz CS (2005) A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res 33: 201–212.
[33]
Beaudoing E, Freier S, Wyatt JR, Claverie JM, Gautheret D (2000) Patterns of variant polyadenylation signal usage in human genes. Genome Res 10: 1001–1010.
[34]
Ji Z, Lee JY, Pan Z, Jiang B, Tian B (2009) Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc Natl Acad Sci U S A 106: 7028–7033.
[35]
Mayr C, Bartel DP (2009) Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673–684.
[36]
Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB (2008) Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320: 1643–1647.
[37]
Takagaki Y, Seipelt RL, Peterson ML, Manley JL (1996) The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 87: 941–952.
[38]
Veraldi KL, Arhin GK, Martincic K, Chung-Ganster LH, Wilusz J, et al. (2001) hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol Cell Biol 21: 1228–1238.
[39]
Shell SA, Hesse C, Morris SM Jr, Milcarek C (2005) Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection. J Biol Chem 280: 39950–39961.
[40]
Berg MG, Singh LN, Younis I, Liu Q, Pinto AM, et al. (2012) U1 snRNP Determines mRNA Length and Regulates Isoform Expression. Cell 150: 53–64.
[41]
Kaida D, Berg MG, Younis I, Kasim M, Singh LN, et al. (2010) U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 468: 664–668.
[42]
Jenal M, Elkon R, Loayza-Puch F, van Haaften G, Kuhn U, et al. (2012) The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 149: 538–553.
[43]
Valcarcel J, Gebauer F (1997) Post-transcriptional regulation: the dawn of PTB. Curr Biol 7: R705–708.
[44]
Hall-Pogar T, Zhang H, Tian B, Lutz CS (2005) Alternative polyadenylation of cyclooxygenase-2. Nucleic Acids Res 33: 2565–2579.
[45]
Blechingberg J, Lykke-Andersen S, Jensen TH, Jorgensen AL, Nielsen AL (2007) Regulatory mechanisms for 3′-end alternative splicing and polyadenylation of the Glial Fibrillary Acidic Protein, GFAP, transcript. Nucleic Acids Res 35: 7636–7650.
[46]
Le Sommer C, Lesimple M, Mereau A, Menoret S, Allo MR, et al. (2005) PTB regulates the processing of a 3′-terminal exon by repressing both splicing and polyadenylation. Mol Cell Biol 25: 9595–9607.
[47]
Millevoi S, Decorsiere A, Loulergue C, Iacovoni J, Bernat S, et al. (2009) A physical and functional link between splicing factors promotes pre-mRNA 3′ end processing. Nucleic Acids Res 37: 4672–4683.
[48]
Lou H, Helfman DM, Gagel RF, Berget SM (1999) Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3′-terminal exon. Mol Cell Biol 19: 78–85.
[49]
Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69: 3584–3596.
[50]
Buratti E, Dork T, Zuccato E, Pagani F, Romano M, et al. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20: 1774–1784.
[51]
Buratti E, De Conti L, Stuani C, Romano M, Baralle M, et al. (2010) Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J 277: 2268–2281.
[52]
Ayala YM, De Conti L, Avendano-Vazquez SE, Dhir A, Romano M, et al. (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30: 277–288.
[53]
Ayala YM, Pantano S, D’Ambrogio A, Buratti E, Brindisi A, et al. (2005) Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 348: 575–588.
[54]
Avendano-Vazquez SE, Dhir A, Bembich S, Buratti E, Proudfoot N, et al. (2012) Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev 26: 1679–1684.
[55]
Danckwardt S, Kaufmann I, Gentzel M, Foerstner KU, Gantzert AS, et al. (2007) Splicing factors stimulate polyadenylation via USEs at non-canonical 3′ end formation signals. EMBO J 26: 2658–2669.
[56]
Shi Y, Di Giammartino DC, Taylor D, Sarkeshik A, Rice WJ, et al. (2009) Molecular architecture of the human pre-mRNA 3′ processing complex. Mol Cell 33: 365–376.
[57]
Freibaum BD, Chitta RK, High AA, Taylor JP (2010) Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 9: 1104–1120.
[58]
Sully G, Dean JL, Wait R, Rawlinson L, Santalucia T, et al. (2004) Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1). Biochem J 377: 629–639.
[59]
Dean JL, Sully G, Clark AR, Saklatvala J (2004) The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal 16: 1113–1121.
[60]
Briata P, Chen CY, Giovarelli M, Pasero M, Trabucchi M, et al. (2011) KSRP, many functions for a single protein. Front Biosci 16: 1787–1796.
[61]
Michlewski G, Caceres JF (2010) Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat Struct Mol Biol 17: 1011–1018.
[62]
Danckwardt S, Gantzert AS, Macher-Goeppinger S, Probst HC, Gentzel M, et al. (2011) p38 MAPK controls prothrombin expression by regulated RNA 3′ end processing. Mol Cell 41: 298–310.
[63]
Barral Y, Kinoshita M (2008) Structural insights shed light onto septin assemblies and function. Curr Opin Cell Biol 20: 12–18.
[64]
Kinoshita M (2006) Diversity of septin scaffolds. Curr Opin Cell Biol 18: 54–60.
[65]
Abdelmohsen K, Tominaga K, Lee EK, Srikantan S, Kang MJ, et al. (2011) Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs. Nucleic Acids Res 39: 8513–8530.
[66]
Mongelard F, Bouvet P (2007) Nucleolin: a multiFACeTed protein. Trends Cell Biol 17: 80–86.
[67]
Kruse C, Willkomm DK, Grunweller A, Vollbrandt T, Sommer S, et al. (2000) Export and transport of tRNA are coupled to a multi-protein complex. Biochem J 346 Pt 1: 107–115.
[68]
Cunningham KS, Dodson RE, Nagel MA, Shapiro DJ, Schoenberg DR (2000) Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3′-untranslated region by the mRNA endonuclease polysomal ribonuclease 1. Proc Natl Acad Sci U S A 97: 12498–12502.
[69]
Woo HH, Yi X, Lamb T, Menzl I, Baker T, et al. (2011) Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer. Mol Cell Biol 31: 215–225.
[70]
Fuller-Pace FV (2006) DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res 34: 4206–4215.
[71]
Hartman TR, Qian S, Bolinger C, Fernandez S, Schoenberg DR, et al. (2006) RNA helicase A is necessary for translation of selected messenger RNAs. Nat Struct Mol Biol 13: 509–516.
[72]
Manojlovic Z, Stefanovic B (2012) A novel role of RNA helicase A in regulation of translation of type I collagen mRNAs. RNA 18: 321–334.
